Abstract:Objective To explore the application value of intravenous iron and oral iron in the clinical treatment of hemodialysis (HD) anemia.Methods A total of 125 patients with HD anemia admitted to our hospital from January 2018 to May 2019 were selected as the study objects.They were divided into vein group (n=62) and oral group (n=63)according to the random number table method.The oral group was treated with Polysaccharide Iron Complex Capsules,the vein group was treated with Sucrose Iron injection.The levels of hemoglobin (Hb), serum ferritin (SF) before and after treatment were compared between the two groups.Results After treatment, the levels of Hb and SF in venous group were higher than those in oral group, the differences were statistically significant (P<0.05).The total effective rate of vein group was 95.16%, which was higher than that of oral group (80.95%), the difference was statistically significant (P<0.05).The incidence of complications in vein group was 4.84%, which was lower than that in control group(17.46%), the difference was statistically significant (P<0.05).Conclusion In the treatment of HD anemia related patients, intravenous iron treatment can effectively improve the level of Hb and SF in the course of treatment, improve the clinical treatment effect of patients, reduce the incidence of complications, and the effect is ideal.
叶水莲; 黄永红. 静脉铁剂与口服铁剂在血液透析贫血患者临床治疗中的应用价值[J]. 中国当代医药, 2020, 27(11): 56-58.
YE Shui-lian; HUANG Yong-hong. Application value of intravenous iron and oral iron in the clinical treatment of hemodialysis anemia. 中国当代医药, 2020, 27(11): 56-58.
Coronado Daza J,Martí-Carvajal AJ,Ariza García A,et al.Early versus delayed erythropoietin for the anaemia of endstage kidney disease[J].Cochrane Database Syst Rev,2015(12):CD011122.
[4]
Zebrowski P,Mieczkowski M.Erythropoietin stimulating agents in chronic kidney disease:indications and contraindications[J].Wiad Lek,2016,69(5):753-755.
[5]
Locatelli F,Del Vecchio L.New strategies for anaemia management in chronic kidney disease[J].Contrib Nephrol,2017,189:184-188.
[6]
Rostoker G,Vaziri ND,Fishbane S.Iatrogenic iron over-load in dialysis patients at the beginning of the 21stcentury[J].Drugs,2016,76(7):741-757.